£86 million funding announced for new medicine and technology

posted 19 Jul 2017, 03:56 by Ray Waters

The government has announced new funding of up to £86 million for UK firms to develop medical breakthroughs.

The package will allow small and medium sized enterprises (SMEs) to develop and test new technologies in the NHS. This could include innovations such as digital technologies to help patients manage their conditions from home instead of a hospital, or to develop new medicines.

Access to this funding will also speed up the time it takes to get new technologies from the lab to patients in the NHS.

The announcement is the first step in taking forward the Accelerated Access Review (AAR) – an independently chaired review, which made recommendations to government on speeding up patient access to new technologies.

Innovation and Technology Tariff (ITT)

posted 4 Jul 2017, 05:31 by Ray Waters

Innovation and Technology Tariff (ITT)
The ITT, operational from April 2017,will remove the need for multiple price negotiations between providers and suppliers, and instead guarantee automatic reimbursement when an approved innovation is used, see AHSN website for further info. 

NHS Expo2015

posted 13 Oct 2015, 07:31 by Ray Waters

MRC Molecular Pathology Node awarded to Newcastle

posted 9 Oct 2015, 08:10 by Ray Waters   [ updated 19 Jul 2017, 03:59 ]

The 'Proximity Laboratory' will focus on developing new tests for rare and chronic diseases. This will further enhance diagnostic development capacity centred at Newcastle.

Longitude Prize opens for entries on 18th November 2014

posted 14 Nov 2014, 03:12 by Ray Waters   [ updated 14 Nov 2014, 03:17 ]

Longitude Prize opens for entries on 18th November 2014 and will reward a new way to test patients and help target antibiotics effectively, contributing to a major reduction in antibiotic use across the world. Diagnostics will have a key role to play in this battle. Point-of-care test kits will allow more targeted use of antibiotics, and an overall reduction in misdiagnosis and prescription. Effective and accurate point of care tests will form a vital part of the toolkit for stewardship of antibiotics in the future. This will ensure that the antibiotics we have now will be effective for longer and we can continue to control infections during routine and major procedures.

See the Longitude Prize  websitefor more information www.longitudeprize.org 

1-6 of 6